Search
for
Sort by
Research 481–510 of 1000+
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Injectable platelet-rich fibrin promotes proliferation and trichogenic inductivityof dermal papilla cells through activating TGF-β/Smad signaling pathway
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- Steroid sulfatase inhibitors
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Development and Validation of Androgen-induced Hair Loss and Anagen Induction Mouse Models for Pharmacological Evaluation of Anti-Androgenic Agents
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Antiandrogens: Clinical applications
- The SH-1 Molecule By Dr. Melvin Sewell
- The SH-1 Molecule By Dr. Melvin Sewell
- Emerging pharmacotherapies for Androgenetic Alopecia
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Improvement of female pattern hair loss with bicalutamide: a time-dependent process
- Bicalutamide in Dermatology: A Narrative Review
- Mechanism exploration of the combined use of minoxidil with natural compounds ginsenoside Rg3 and glycyrrhizic acid for enhancing androgenic alopecia therapy
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats
- Expression Profiles of Reproduction- and Thyroid Hormone-Related Transcripts in the Brains of Chemically-Induced Intersex Frogs
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Updates in Treatment for Androgenetic Alopecia
- The Pathogenesis and Treatment Progress of Androgenic Alopecia
- Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Hair loss improvement effect of Chrysanthemum zawadskii, peppermint and Glycyrrhiza glabra herbal mixture in human follicle dermal papilla cell and C57BL/6 mice